Discover the full insider trade history of 티움바이오, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 티움바이오 has recorded 2 reports. Market capitalisation: €244.3bn. The latest transaction was disclosed on 24 April 2026 — Sale. Among the most active insiders: 김훈택. All data is free.